BIODESIX INC (BDSX) Stock Analyst Earnings Estimates
NASDAQ:BDSX - Nasdaq - US09075X1081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 54.51M 19.64% | 38.21M -29.90% | 49.087M 28.47% | 72.144M 46.97% | 94.979M 31.65% | 117.67M 23.89% | |
| EBITDA YoY % growth | -37.76M -88.52% | -46.91M -24.23% | -37.97M 19.06% | -24.072M 36.60% | -9.639M 59.96% | -510K 94.71% | |
| EBIT YoY % growth | -40.94M -78.54% | -50.51M -23.38% | -41.298M 18.24% | -36.403M 11.85% | -25.977M 28.64% | -18.122M 30.24% | |
| Operating Margin | -75.11% | -132.19% | -84.13% | -50.46% | -27.35% | -15.40% | |
| EPS YoY % growth | -1.54 -18.88% | -1.59 -3.25% | -0.65 59.12% | -0.36 46.15% | -0.22 36.86% | -0.16 29.23% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 49.00% | -0.06 26.05% | -0.06 21.31% | -0.05 21.80% |
| Revenue Q2Q % growth | 20.647M 39.34% | 23.081M 28.76% | 24.109M 32.82% | 26.055M 27.53% |
| EBITDA Q2Q % growth | -4.284M 55.06% | -4.182M 21.66% | -3.162M 25.90% | -2.244M 59.26% |
| EBIT Q2Q % growth | -8.738M 20.22% | -6.936M 15.10% | -6.477M 24.61% | -6.069M 24.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.06 40.00% | -0.07 | 0.01 | 11.77% |
| Q3 2024 Q2Q % growth | -0.07 50.00% | -0.07 | 0.00 | 6.41% |
| Q2 2024 Q2Q % growth | -0.08 52.94% | -0.09 | 0.01 | 14.75% |
| Q1 2024 Q2Q % growth | -0.14 41.67% | -0.15 | 0.01 | 4.24% |
| Q4 2023 Q2Q % growth | -0.10 71.43% | -0.11 | 0.01 | 10.87% |
| Q3 2023 Q2Q % growth | -0.14 58.82% | -0.15 | 0.01 | 8.50% |
| Q2 2023 Q2Q % growth | -0.17 57.50% | -0.21 | 0.04 | 19.36% |
| Q1 2023 Q2Q % growth | -0.24 52.00% | -0.24 | 0.00 | 0.58% |
| Q4 2022 Q2Q % growth | -0.35 28.57% | -0.28 | -0.07 | -23.65% |
| Q3 2022 Q2Q % growth | -0.34 17.07% | -0.33 | -0.01 | -1.78% |
| Q2 2022 Q2Q % growth | -0.40 2.44% | -0.47 | 0.07 | 15.67% |
| Q1 2022 Q2Q % growth | -0.50 -117.39% | -0.41 | -0.09 | -21.54% |
| Q4 2021 Q2Q % growth | -0.49 -96.00% | -0.50 | 0.01 | 1.96% |
| Q3 2021 Q2Q % growth | -0.41 98.72% | -0.49 | 0.08 | 15.82% |
| Q2 2021 Q2Q % growth | -0.41 | -0.29 | -0.12 | -40.22% |
| Q1 2021 Q2Q % growth | -0.23 | -0.18 | -0.05 | -28.85% |
| Q4 2020 Q2Q % growth | -0.25 | -0.45 | 0.20 | 44.30% |
| Q3 2020 Q2Q % growth | -31.93 | -6.92 | -25.01 | -361.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 20.43M 39.28% | 20.279M | 151K | 0.74% |
| Q3 2024 Q2Q % growth | 18.151M 34.54% | 18.984M | -833K | -4.39% |
| Q2 2024 Q2Q % growth | 17.925M 50.99% | 16.538M | 1.387M | 8.39% |
| Q1 2024 Q2Q % growth | 14.818M 63.63% | 14.464M | 354K | 2.45% |
| Q4 2023 Q2Q % growth | 14.668M 52.63% | 15.919M | -1.251M | -7.86% |
| Q3 2023 Q2Q % growth | 13.491M 21.43% | 14.647M | -1.156M | -7.89% |
| Q2 2023 Q2Q % growth | 11.872M 8.42% | 11.905M | -33K | -0.28% |
| Q1 2023 Q2Q % growth | 9.056M 38.26% | 8.891M | 165K | 1.86% |
| Q4 2022 Q2Q % growth | 9.61M 33.10% | 10.987M | -1.377M | -12.53% |
| Q3 2022 Q2Q % growth | 11.11M 70.14% | 10.37M | 740K | 7.14% |
| Q2 2022 Q2Q % growth | 10.95M -7.91% | 8.995M | 1.955M | 21.73% |
| Q1 2022 Q2Q % growth | 6.55M -77.31% | 6.596M | -46K | -0.70% |
| Q4 2021 Q2Q % growth | 7.22M -73.29% | 7.684M | -464K | -6.04% |
| Q3 2021 Q2Q % growth | 6.53M -28.94% | 6.298M | 232K | 3.68% |
| Q2 2021 Q2Q % growth | 11.89M 27.37% | 21.565M | -9.675M | -44.86% |
| Q1 2021 Q2Q % growth | 28.87M | 26.774M | 2.096M | 7.83% |
| Q4 2020 Q2Q % growth | 27.03M 10.09% | 15.761M | 11.269M | 71.50% |
| Q3 2020 Q2Q % growth | 9.19M | 8.63M | 560K | 6.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.43% | 0% | 0% |
| Revenue | 0% | 0.23% | 0% | 0% |